期刊
DIABETES
卷 66, 期 5, 页码 1293-1300出版社
AMER DIABETES ASSOC
DOI: 10.2337/db16-0887
关键词
-
资金
- JDRF [2-2005-946, 46-2010-755, 26-2007-928, 17-2012-389]
- KAKENHI [10379258]
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK-089566, DK-089572, DK-50203, DK-090570]
- Swiss National Science Foundation
- Grants-in-Aid for Scientific Research [15K09388] Funding Source: KAKEN
Among the therapeutic avenues being explored for replacement of the functional islet -cell mass lost in type 1 diabetes (T1D), reprogramming of adult cell types into new -cells has been actively pursued. Notably, mouse islet -cells will transdifferentiate into -cells under conditions of near -cell loss, a condition similar to T1D. Moreover, human islet -cells also appear to poised for reprogramming into insulin-positive cells. Here we have generated transgenic mice conditionally expressing the islet -cell-enriched Mafa and/or Pdx1 transcription factors to examine their potential to transdifferentiate embryonic pan-islet cell Ngn3-positive progenitors and the later glucagon-positive -cell population into -cells. Mafa was found to both potentiate the ability of Pdx1 to induce -cell formation from Ngn3-positive endocrine precursors and enable Pdx1 to produce -cells from -cells. These results provide valuable insight into the fundamental mechanisms influencing islet cell plasticity in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据